Eiger BioPharma: 2Q Earnings Snapshot
PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $15.3 million in its second quarter.
The Palo Alto, California-based company said it had a loss of 60 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.
Eiger BioPharma shares have dropped 26% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.96, a climb of 11% in the last 12 months.